Login Contact Us
Jul 2018, Vol 6, Issue 3
Advanced Search
How do you find the scientific quality of the published articles on our web site?
Case Report
Uterine Leiomyosarcoma: A Case Report
Forough Forghani1, Abolfazl Mehdizadeh Kashi2, Kambiz Sadegi3,4, Mania Kaveh2,1, Mehrangiz Ghafari5
1Department of Obstetrics and Gynecology, Zabol University of Medical Sciences, Zabol, Iran
2Endometriosis and Gynecological Disorder Research Center, Iran University of Medical Sciences, Tehran, Iran
3Pain Research Center, Iran University of Medical Sciences, Tehran, Iran
4Department of Anesthesiology, Zabol University of Medical Sciences, Zabol, Iran
5Department of Pathology, Zabol University of Medical Sciences, Zabol, Iran

IJWHR 2018; 6: 390-392
DOI: 10.15296/ijwhr.2018.64
Viewed : 2690 times
Downloaded : 2515 times.

Keywords : Uterine leiomyosarcoma, Gynecologic oncologist
Full Text(PDF) | Related Articles
Objectives: Uterine leiomyosarcoma (LMS) is a rare cancer originated from smooth muscle lining the walls of the uterus. LMS is known as an aggressive tumor with high mortality and morbidity rates compared to other uterine cancers, despite the disease stage at the time of diagnosis. In most cases, LMS has been misdiagnosed as benign uterine leiomyoma following hysterectomy or myomectomy.

Case Presentation: We present a 53-year-old G7 L7 woman who was referred to our clinic for abnormal uterine bleeding (AUB) for 6 months. On physical examination, we found an abdominal mass that had grown rapidly in the last 4 months. The computed tomography (CT) scan results showed a heterogeneous mass extending from the epigastric region to the pelvic area. Following an exploratory laparotomy, histopathology report confirmed the diagnosis of LMS. Her uterus, Fallopian tubes and ovaries were removed during a surgery, and she was referred to a gynecologic oncologist for possible chemotherapy.

Conclusions: We found that the surgery was the only treatment for LMS. Although there is a faint possibility to diagnose LMS before surgery, in the patient with uncertain diagnosis and suspicious of LMS, analysis of LDH and LDH3 levels along with dynamic gadolinium- diethylenetriamine penta-acetic acid (Gd-DTPA) enhanced magnetic resonance imaging (MRI) is recommended.

Cite By, Google Scholar

Google Scholar

Articles by Forghani F
Articles by Mehdizadeh Kashi A
Articles by Sadegi K
Articles by Kaveh M
Articles by Ghafari M


Articles by Forough Forghani
Articles by Kambiz Sadegi
Articles by Mania Kaveh
Articles by Mehrangiz Ghafari

Submit Paper
Online Submission System
IJWHR ENDNOTE ® Style Tutorials Publication Charge Women's Reproductive Health Research Center About Journal
Publication Information
Published Article Statistics